MELA Sciences Responds to Congressional Testimony on Medical Device Regulation at the FDA

MELA Sciences issued statements after yesterday’s hearing on “Regulatory Reform Series No. 5 - FDA Medical Device Regulation: Impact on American Patients, Innovation and Jobs” by the U.S. House Committee on Energy and Commerce’s Subcommittee on Oversight and Investigations.
MarketWatch